Prevention strategies in patients at high-risk for Candida infections: data from a neonatal intensive care setting

Intensive Care Med. 2006 Jun;32(6):936; author reply 935. doi: 10.1007/s00134-006-0165-y. Epub 2006 Apr 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Candida / drug effects*
  • Cross Infection / prevention & control*
  • Humans
  • Intensive Care Units, Neonatal*
  • Nystatin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Nystatin